Diabetes, Heart and Cardiovascular Diseases News Chronicle.  Diabetes, Cardiovascular and Heart Diseases
 Article 275
    Published on December 5, 2017

Newly identified pancreatogenic diabetes or type 3c diabetes (T3cD) getting wrongly diagnosed with type 2 diabetes (T2D)

Researchers have identified new type 3c diabetes (also known as pancreatogenic diabetes T3cD). Damage to the pancreas due to tumors, inflammation or surgery causes the development of type 3c diabetes. This type of diabetes weakens the insulin production from beta cells (to control blood glucose levels or glycemic control) and also weakens the production of digestive enzymes (proteins) and other hormones (for the digestion of the food). Diabetes may not be developed in all people with pancreas diseases, damage or injury. Diabetes development may take more than 10 years in most of the people with pancreatic diseases, damage or injury.

Medical professionals are wrongly diagnosing most of the type 3c diabetes conditions as type 2 diabetes (T2D) conditions. Diagnosis of type 3c diabetes is being overlooked due to the long delay in the development of type 3c diabetes and medical professionals failed to link pancreas diseases, damage or injury to the pancreatogenic diabetes or type 3c diabetes (T3cD) disease developing.

A large-scale study was conducted among 2 million patients, all age groups, in England. Researchers used the Royal College of General Practitioners Research and Surveillance Database (RCGP RSC) to find out the prevalence of type 3c diabetes. The study also focused on finding how type 3c diabetes patients are controlling their blood sugar levels.

Researchers looked into those patient records who were diagnosed with diabetes after receiving damage to pancreas with events such as hemochromatosis, cystic fibrosis, pancreatic cancer and tumors, pancreatitis and pancreatic surgery, which may increase the risk of the development of type 3c diabetes or pancreatogenic diabetes (T3cD). The study finding among newly diagnosed adult diabetes patients are

  • Only three percent of the new adult type 3c diabetes patients were being diagnosed properly as type 3c diabetes.
  • Type 3c diabetes was more prevalent than type 1 diabetes (T1D). New diabetes patients with type 1 diabetes (T1D) were one percent and with type 3c diabetes were 1.6 percent.
  • Management of blood sugar levels is twice more likely to be poor among type 3c diabetes patients when compared with type 2 diabetes (T2D) patients.
  • Insulin requirement among type 3c diabetes patients depends upon the type of pancreas disease, damage or injury. Insulin requirement will be five to ten times more likely compared with those people with type 2 diabetes (T2D).

Type 3c diabetes risk with hemochromatosis cystic fibrosis pancreatic cancer tumor surgery pancreatitis.

These results increase concerns that the type 3c diabetes is more common and this type of diabetes is not being diagnosed properly. The wrong diagnosis of type diabetes is a waste of time, money and a risk of high blood sugar or glucose levels. Type 2 diabetes (T2D) treatment and drugs such as gliclazide are not effective in the treatment of type 3c diabetes. Small study results show type 3c diabetes patients will be benefited by taking insulin injection and also digestive enzymes (in a tablet, liquid or pill form) along with the food. Some tips to prevent the development of type 3c diabetes or pancreatogenic diabetes (T3cD) are

  • Eating fresh vegetables and fruits
  • Regular physical exercise or workouts
  • Reducing alcohol consumption
  • Avoiding fried and fatty food
  • Avoiding tobacco usage

Facebook     GooglePlus     Twitter
If you like this article, please share it with a friend! Article address is (copy and paste the code below) :

Articles similar to this topic

1. Restoring Insulin Production
2. Risk for type 2 diabetes, type 1.5 diabetes or latent autoimmune diabetes in adults (LADA) with high salt or sodium consumption
3. Research On Cystic Fibrosis Related Diabetes CFRD Disease
4. Better HbA1c A1C or glycemic control without hypoglycemic events with Dapagliflozin (Forxiga) drug in type 1 diabetic patients
5. Weight loss and improved blood sugar or glucose levels (glycemic control) with an EndoBarrier device
6. About Glycemic Index GI Of Food Item
7. Mouse Study Suggests Fasting Diet May Regenerate Pancreas And Reverse Diabetes Effects
8. Risk Of Pancreas Inflammation With Gliptin Treatment
9. Artificial Pancreas, Automated Insulin Delivery System From Bigfoot Biomedical
10. Benefits With Closed-Loop Artificial Pancreas
11. Study Of Artificial Pancreas
12. New Approach To Stimulate Beta Cells
13. New Blood Glycated Protein CD59 Or GCD59 Test To Diagnose Gestational Diabetes Early
14. Kidney failure, amputations, blindness, heart attack and stroke complications by delaying insulin therapy among type 2 diabetes patients
15. Raspberries could lower inflammation, high blood sugar or glucose levels and improves insulin sensitivity
16. Urocortin 2 (Ucn2) gene transfer therapy improves insulin sensitivity and reduces blood sugar or glucose (HbA1c) levels
17. A single dose of glucagon receptor antibody found to be as effective in reducing the insulin need
18. Prevention of heart diseases with an extra injection of insulin after meals in type 1 diabetes patients


Pancreatitis : Pancreas organ produces glucagon and insulin hormones and releases them into the bloodstream to control blood sugar levels. The organ also produces digestive enzymes and releases them into the small intestine for the digestion of the food. Sometimes, these digestive enzymes were activated before being released into the small intestine. These enzymes start attacking pancreas organ itself causing inflammation of the pancreas. This inflammation causes pancreatitis disease. Symptoms of pancreatitis disease are

  • Nausea and vomiting
  • Enhanced heartbeat or pulse
  • Upper abdominal pain
  • Lethargy and weakness
  • Pain after eating food
  • Changes in the stool (poop or feces) color



Site maps

Site map 1   Site map 2   Site map 3   Site map 4

The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.

Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.